A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis

NCT01667094 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Intermittent, short infusion Ceftazidime
DRUG: Continuous infusion Ceftazidime
DRUG: Intermittent, short infusion Meropenem
DRUG: Continuous infusion Meropenem
DRUG: Intermittent, short infusion Ticarcillin-clavulanate
DRUG: Continuous infusion Ticarcillin-clavulanate
DRUG: Intermittent, short infusion Cefepime
DRUG: Continuous infusion Cefepime
DRUG: Continuous infusion Piperacillin tazobactam
DRUG: Intermittent, short infusion Piperacillin tazobactam

Sponsor

The Alfred